SE7612295L - Antibiotikum - Google Patents

Antibiotikum

Info

Publication number
SE7612295L
SE7612295L SE7612295A SE7612295A SE7612295L SE 7612295 L SE7612295 L SE 7612295L SE 7612295 A SE7612295 A SE 7612295A SE 7612295 A SE7612295 A SE 7612295A SE 7612295 L SE7612295 L SE 7612295L
Authority
SE
Sweden
Prior art keywords
deacetyl
antibiotics
gram
thienamycin
antibiotic
Prior art date
Application number
SE7612295A
Other languages
English (en)
Swedish (sv)
Inventor
J S Kahan
F M Kahan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7612295L publication Critical patent/SE7612295L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
SE7612295A 1975-11-24 1976-11-04 Antibiotikum SE7612295L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63456075A 1975-11-24 1975-11-24

Publications (1)

Publication Number Publication Date
SE7612295L true SE7612295L (sv) 1977-05-25

Family

ID=24544292

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612295A SE7612295L (sv) 1975-11-24 1976-11-04 Antibiotikum

Country Status (16)

Country Link
JP (1) JPS5265295A (enExample)
AR (1) AR224224A1 (enExample)
AU (1) AU510252B2 (enExample)
BE (1) BE848349A (enExample)
CH (1) CH625803A5 (enExample)
DE (1) DE2652678A1 (enExample)
DK (1) DK497476A (enExample)
ES (1) ES453508A1 (enExample)
FR (1) FR2351979A1 (enExample)
GB (1) GB1561108A (enExample)
GR (1) GR61407B (enExample)
HU (1) HU175266B (enExample)
NL (1) NL7612932A (enExample)
PT (1) PT65845B (enExample)
SE (1) SE7612295L (enExample)
ZA (1) ZA766986B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7800958A (nl) * 1977-02-11 1978-08-15 Merck & Co Inc Antibioticum desacetyl-dihydro 890 a9, werkwijze ter bereiding daarvan en farmaceutisch preparaat dat dit antibioticum bevat.
SE7800978L (sv) * 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
US4162193A (en) * 1977-08-19 1979-07-24 Merck & Co., Inc. Enzymatic cleavage of N-acyl-thienamycins
NZ190994A (en) 1978-07-24 1981-10-19 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates
DE2965923D1 (en) * 1979-08-28 1983-08-25 Merck & Co Inc Process for purifying thienamycin
DE3146190A1 (de) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen
WO2017132321A1 (en) * 2016-01-29 2017-08-03 The Johns Hopkins University Novel inhibitors of bacterial growth

Also Published As

Publication number Publication date
FR2351979A1 (fr) 1977-12-16
PT65845A (en) 1976-12-01
ZA766986B (en) 1978-06-28
JPS5265295A (en) 1977-05-30
PT65845B (en) 1978-10-10
AU510252B2 (en) 1980-06-19
ES453508A1 (es) 1978-03-01
AU1964576A (en) 1978-05-25
GB1561108A (en) 1980-02-13
FR2351979B1 (enExample) 1982-08-13
NL7612932A (nl) 1977-05-26
BE848349A (fr) 1977-05-16
GR61407B (en) 1978-11-11
CH625803A5 (en) 1981-10-15
AR224224A1 (es) 1981-11-13
DK497476A (da) 1977-05-25
DE2652678A1 (de) 1977-06-02
HU175266B (hu) 1980-06-28

Similar Documents

Publication Publication Date Title
ES468475A1 (es) Procedimiento para la preparacion de derivados de cefem
SE8605405D0 (sv) Forfarande for framstellning av ett salt av klavulansyra
SE7902954L (sv) Tiazolylettiksyraforeningar
SE7706877L (sv) Kemiska mellanprodukter
ES499485A0 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
FI923747A7 (fi) Koostumuksia ja menetelmiä b-laktaamiantibiooteille herkkien organismi en aiheuttamien infektioiden hoitamiseksi
SE7611047L (sv) Forfarande for framstellning av antibakteriella emnen
SE7612295L (sv) Antibiotikum
SE7704301L (sv) Antibiotika
SE7612962L (sv) Tienamycinderivat
SE7508570L (sv) Forfarande for framstellning av cefalosporinforeningar
SE7908896L (sv) Cefalosporinforeningar
IL35875A (en) Pharmaceutical compositions for the treatment of microbial infections containing an n-(3-carboxy-propionyl)glutamic acid derivative
SE8500965D0 (sv) Mellanprodukter for framstellning av beta-laktamasinhibitorer
ES8105147A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas de actividad antibacteriana
SE7909501L (sv) Cefalosporin-antibiotika
JPS54154785A (en) Cephem derivative and its manufacture
SE7514646L (sv) Cefalosporinderivat och forfarande for framstellning derav.
SE7612963L (sv) Tienamycinderivat
GB1028563A (en) Antibacterial derivative of 7-aminocephalosporanic acid
SE7908895L (sv) Cefalosporinforeningar
GB1470329A (en) Antibiotic derivatives of xk-62-2 and method of production thereof
SE7612960L (sv) Tienamycinderivat
ES436198A1 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina sustituidas.
ES454009A1 (es) Un procedimiento para la preparacion de nuevos esteres de derivados del acido clavulanico.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612295-1

Format of ref document f/p: F